Lockheed Martin (LMT) stock tumbled Tuesday as the defense contractor reported $1.6 billion in losses across a range of programs and slashed its full-year profit forecast.
LMT beats on Q2 earnings but slashes 2025 EPS outlook despite steady sales and cash flow targets.
Lockheed Martin Corp (NYSE:LMT) stock tumbled more than 5% in early trade as program losses hit its profits for the second quarter. The defense and aerospace firm reported pre-tax losses on programs of $1.6 billion and other charges of $169 million, which impacted earnings per share by $5.83.
Defense stock Lockheed Martin Corp (NYSE:LMT) was last seen down 8.4% at $422, after the company recorded a $1.6 billion in loss attributed to its classified programs, cutting deeply into second-quarter profits.
Although the revenue and EPS for Lockheed (LMT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lockheed Martin (LMT) came out with quarterly earnings of $7.29 per share, beating the Zacks Consensus Estimate of $6.49 per share. This compares to earnings of $7.11 per share a year ago.
Lockheed Martin's stock led the S&P 500's early decliners after a $1.6 billion charge led to a big profit miss.
There's a lot to like about defense giant Lockheed Martin's (LMT -1.09%) stock, but is it enough to make it an investment that investors can feel comfortable with, knowing it will generate life-changing long-term returns?
The latest trading day saw Lockheed Martin (LMT) settling at $463.96, representing a -1.12% change from its previous close.
Lockheed (LMT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Get a deeper insight into the potential performance of Lockheed (LMT) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
LMT's Q2 sales are likely to have risen across all segments, but dismal earnings expectations and weak price performance raise caution.